Literature DB >> 16491011

Puberty in subjects with complete androgen insensitivity syndrome.

Dimitrios T Papadimitriou1, Agnès Linglart, Yves Morel, Jean-Louis Chaussain.   

Abstract

BACKGROUND: Androgen receptor defects affect the regulation of the gonadotropic axis. However, little is known about the timing of pubertal maturation in complete androgen insensitivity syndrome (CAIS). AIMS: To evaluate growth, skeletal maturation and gonadotropin and sex steroid secretion in patients with CAIS and intact gonads at puberty.
METHODS: Clinical, auxological and hormonal evaluation of 9 patients with CAIS from birth up to 17 years of age, prior to gonadectomy, in a single institution, retrospective study.
RESULTS: Breast development occurred at a median age of 11.1 years, thumb sesamoid appeared at 11.5 years, and peak height velocity at 12.3 years, all consistent with average female values. However, median adult male height (+1.2 SDS) was closer to the patients' male target height (-0.3 SDS). Plasma testosterone levels rose early compared to normal boys. LH (basal and GnRH-stimulated) increased rapidly, above normal male values, in early puberty.
CONCLUSIONS: This retrospective evaluation of a limited number of cases with a heterogeneous pattern of follow-up suggests that patients with CAIS may enter puberty at an age closer to female standards. These results imply a major role of direct androgen action, in utero or in early life, in determining the pattern of pubertal gonadotropin maturation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491011     DOI: 10.1159/000091592

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  8 in total

1.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

2.  Growth Curves of Chinese Children with Androgen Insensitivity Syndrome: A Multicenter Registry Study.

Authors:  Xiu Zhao; Zhe Su; Shaoke Chen; Xiumin Wang; Yu Yang; Linqi Chen; Li Liang; Geli Liu; Yi Wang; Yanning Song; Lijun Fan; Xiaoya Ren; Chunxiu Gong
Journal:  J Pers Med       Date:  2022-05-10

Review 3.  Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.

Authors:  Eric P Smith; Bonny Specker; Kenneth S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-10       Impact factor: 4.292

Review 4.  The differential role of androgens in early human sex development.

Authors:  Olaf Hiort
Journal:  BMC Med       Date:  2013-06-24       Impact factor: 8.775

Review 5.  Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS).

Authors:  Lucia Lanciotti; Marta Cofini; Alberto Leonardi; Mirko Bertozzi; Laura Penta; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-04-09       Impact factor: 3.390

6.  Transgender Girls Grow Tall: Adult Height Is Unaffected by GnRH Analogue and Estradiol Treatment.

Authors:  Lidewij Sophia Boogers; Chantal Maria Wiepjes; Daniel Tatting Klink; Ilse Hellinga; Adrianus Sarinus Paulus van Trotsenburg; Martin den Heijer; Sabine Elisabeth Hannema
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

7.  Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature.

Authors:  Sahra Steinmacher; Sara Y Brucker; Andrina Kölle; Bernhard Krämer; Dorit Schöller; Katharina Rall
Journal:  Int J Environ Res Public Health       Date:  2021-05-25       Impact factor: 3.390

8.  Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.

Authors:  D T Papadimitriou; E Dermitzaki; M Papagianni; G Papaioannou; V Papaevangelou; A Papadimitriou
Journal:  J Endocrinol Invest       Date:  2015-10-27       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.